Crossref journal-article
Elsevier BV
Cell (78)
Bibliography

Grimmler, M., Wang, Y., Mund, T., Cilenšek, Z., Keidel, E.-M., Waddell, M. B., Jäkel, H., Kullmann, M., Kriwacki, R. W., & Hengst, L. (2007). Cdk-Inhibitory Activity and Stability of p27 Are Directly Regulated by Oncogenic Tyrosine Kinases. Cell, 128(2), 269–280.

Authors 10
  1. Matthias Grimmler (first)
  2. Yuefeng Wang (additional)
  3. Thomas Mund (additional)
  4. Zoran Cilenšek (additional)
  5. Eva-Maria Keidel (additional)
  6. M. Brett Waddell (additional)
  7. Heidelinde Jäkel (additional)
  8. Michael Kullmann (additional)
  9. Richard W. Kriwacki (additional)
  10. Ludger Hengst (additional)
References 42 Referenced 289
  1. 10.1158/0008-5472.CAN-04-1357 / Cancer Res. / BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells by Andreu (2005)
  2. 10.1074/jbc.272.41.25863 / J. Biol. Chem. / Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4 by Blain (1997)
  3. 10.1016/S1535-6108(03)00026-6 / Cancer Cell / p27 as a target for cancer therapeutics by Blain (2003)
  4. 10.1016/S1044-579X(02)00098-6 / Semin. Cancer Biol. / Deregulated degradation of the cdk inhibitor p27 and malignant transformation by Bloom (2003)
  5. 10.1016/0076-6879(91)01013-R / Methods Enzymol. / Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates by Boyle (1991)
  6. 10.1093/emboj/18.6.1571 / EMBO J. / The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts by Cheng (1999)
  7. 10.1016/j.cell.2006.11.049 / Cell / p27 phosphorylation by Src regulates inhibition of Cyclin E-Cdk2 by Chu (2007)
  8. 10.1128/MCB.22.9.2993-3002.2002 / Mol. Cell. Biol. / Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest by Ciarallo (2002)
  9. 10.1038/sj.onc.1203398 / Oncogene / v-Abl utilizes multiple mechanisms to drive G1/S progression in fibroblasts by Coutts (2000)
  10. {'key': '10.1016/j.cell.2006.11.047_bib10', 'first-page': '3589', 'article-title': 'Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells', 'volume': '56', 'author': 'Danhauser-Riedl', 'year': '1996', 'journal-title': 'Cancer Res.'} / Cancer Res. / Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells by Danhauser-Riedl (1996)
  11. 10.1182/blood.V101.2.690 / Blood / BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571 by Donato (2003)
  12. 10.1091/mbc.9.8.2081 / Mol. Biol. Cell / Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells by Dong (1998)
  13. 10.1074/jbc.M007291200 / J. Biol. Chem. / BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway by Gesbert (2000)
  14. {'key': '10.1016/j.cell.2006.11.047_bib14', 'first-page': '1581', 'article-title': 'Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins', 'volume': '11', 'author': 'Hall', 'year': '1995', 'journal-title': 'Oncogene'} / Oncogene / Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins by Hall (1995)
  15. {'key': '10.1016/j.cell.2006.11.047_bib15', 'first-page': '1367', 'article-title': 'Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines', 'volume': '25', 'author': 'Hallek', 'year': '1997', 'journal-title': 'Exp. Hematol.'} / Exp. Hematol. / Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines by Hallek (1997)
  16. 10.1126/science.271.5257.1861 / Science / Translational control of p27Kip1 accumulation during the cell cycle by Hengst (1996)
  17. {'key': '10.1016/j.cell.2006.11.047_bib17', 'first-page': '25', 'article-title': 'Inhibitors of the Cip/Kip family', 'volume': '227', 'author': 'Hengst', 'year': '1998', 'journal-title': 'Curr. Top. Microbiol. Immunol.'} / Curr. Top. Microbiol. Immunol. / Inhibitors of the Cip/Kip family by Hengst (1998)
  18. 10.1101/gad.12.24.3882 / Genes Dev. / Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1) by Hengst (1998)
  19. 10.1038/71691 / Nat. Genet. / Reversibility of acute B-cell leukaemia induced by BCR-ABL1 by Huettner (2000)
  20. 10.1182/blood.V96.5.1933 / Blood / Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines by Jonuleit (2000)
  21. 10.1038/ncb1194 / Nat. Cell Biol. / Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase by Kamura (2004)
  22. 10.1182/blood-2005-05-1771 / Blood / Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4 by Kardinal (2006)
  23. 10.1038/332083a0 / Nature / Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas by Kawano (1988)
  24. 10.1074/jbc.M500866200 / J Biol Chem. / Molecular dissection of the interaction between p27 and KPC, the ubiquitin ligase that regulates proteolysis of p27 in G1 phase by Kotoshiba (2005)
  25. 10.1101/gad.11.7.847 / Genes Dev. / New functional activities for the p21 family of CDK inhibitors by LaBaer (1997)
  26. 10.1038/nsmb746 / Nat. Struct. Mol. Biol. / p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding by Lacy (2004)
  27. 10.1128/MCB.23.11.3735-3752.2003 / Mol. Cell. Biol. / p27Kip1 inhibition of GRB2-SOS formation can regulate Ras activation by Moeller (2003)
  28. 10.1016/S0968-0004(98)01183-9 / Trends Biochem. Sci. / CLAMP: a biosensor kinetic data analysis program by Myszka (1998)
  29. 10.1128/jb.119.3.736-747.1974 / J Bacteriol. / Culture medium for enterobacteria by Neidhardt (1974)
  30. 10.1126/science.7624798 / Science / Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 by Pagano (1995)
  31. 10.1006/jmbi.1999.2640 / J. Mol. Biol. / Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors by Pavletich (1999)
  32. 10.1074/jbc.272.21.13937 / J. Biol. Chem. / Overexpression of the integrin-linked kinase promotes anchorage- independent cell cycle progression by Radeva (1997)
  33. 10.1038/382325a0 / Nature / Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex by Russo (1996)
  34. 10.1128/MCB.01630-05 / Mol. Cell. Biol. / Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein by Sabile (2006)
  35. 10.1073/pnas.95.18.10453 / Proc. Natl. Acad. Sci. USA / Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A by Schulman (1998)
  36. 10.1101/gad.13.12.1501 / Genes Dev. / CDK inhibitors: positive and negative regulators of G1-phase progression by Sherr (1999)
  37. 10.1016/j.jmb.2005.08.074 / J Mol Biol. / Disordered p27Kip1 exhibits intrinsic structure resembling the Cdk2/cyclin A-bound conformation by Sivakolundu (2005)
  38. {'key': '10.1016/j.cell.2006.11.047_bib38', 'first-page': '135', 'article-title': 'Formation of p27-CDK complexes during the human mitotic cell cycle', 'volume': '7', 'author': 'Soos', 'year': '1996', 'journal-title': 'Cell Growth Differ.'} / Cell Growth Differ. / Formation of p27-CDK complexes during the human mitotic cell cycle by Soos (1996)
  39. 10.1074/jbc.M010811200 / J. Biol. Chem. / Direct binding of the signal-transducing adaptor Grb2 facilitates down-regulation of the cyclin-dependent kinase inhibitor p27Kip1 by Sugiyama (2001)
  40. 10.1002/cbic.200500260 / Chembiochem. / Solution NMR studies of an intrinsically unstructured protein within a dilute, 75 kDa eukaryotic protein assembly; probing the practical limits for efficiently assigning polypeptide backbone resonances by Wang (2005)
  41. 10.1007/BF00211164 / J. Biomol. NMR / Genetic tools for selective labeling of proteins with alpha-15N-amino acids by Waugh (1996)
  42. 10.1146/annurev.immunol.22.012703.104753 / Annu. Rev. Immunol. / The BCR-ABL story: bench to bedside and back by Wong (2004)
Dates
Type When
Created 18 years, 6 months ago (Jan. 26, 2007, 12:43 p.m.)
Deposited 2 years, 6 months ago (Jan. 28, 2023, 9:32 a.m.)
Indexed 3 weeks ago (Aug. 2, 2025, 12:43 a.m.)
Issued 18 years, 7 months ago (Jan. 1, 2007)
Published 18 years, 7 months ago (Jan. 1, 2007)
Published Print 18 years, 7 months ago (Jan. 1, 2007)
Funders 0

None

@article{Grimmler_2007, title={Cdk-Inhibitory Activity and Stability of p27 Are Directly Regulated by Oncogenic Tyrosine Kinases}, volume={128}, ISSN={0092-8674}, url={http://dx.doi.org/10.1016/j.cell.2006.11.047}, DOI={10.1016/j.cell.2006.11.047}, number={2}, journal={Cell}, publisher={Elsevier BV}, author={Grimmler, Matthias and Wang, Yuefeng and Mund, Thomas and Cilenšek, Zoran and Keidel, Eva-Maria and Waddell, M. Brett and Jäkel, Heidelinde and Kullmann, Michael and Kriwacki, Richard W. and Hengst, Ludger}, year={2007}, month=jan, pages={269–280} }